Efg Asset Management (North America) Corp. Krystal Biotech, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $705 Million
- Q4 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 17,714 shares of KRYS stock, worth $2.71 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
17,714
Previous 13,529
30.93%
Holding current value
$2.71 Million
Previous $2.46 Million
12.8%
% of portfolio
0.39%
Previous 0.42%
Shares
10 transactions
Others Institutions Holding KRYS
# of Institutions
302Shares Held
24.5MCall Options Held
444KPut Options Held
325K-
Black Rock Inc. New York, NY3.95MShares$605 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$441 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$403 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$196 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$151 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.93B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...